About Opentrons
Opentrons is a company based in Brooklyn (United States) founded in 2013. Opentrons has raised $260.68 million across 7 funding rounds from investors including SoftBank Group, Khosla Ventures and Lerer Hippeau. Opentrons has completed 3 acquisitions, including Zenify, Zenith AI and Zenith Algorithm. Opentrons offers products and services including Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules. Opentrons operates in a competitive market with competitors including Tecan, Andrew Alliance, LabCyte, Ginolis and Scienion, among others.
- Headquarter Brooklyn, United States
- Stage Unicorn
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Opentrons Labworks Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$260.68 M (USD)
in 7 rounds
-
Latest Funding Round
$20.12 M (USD), Series C
Nov 20, 2025
-
Investors
SoftBank Group
& 7 more
-
Employee Count
Not available
-
Investments & Acquisitions
Zenify
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Opentrons
Opentrons offers a comprehensive portfolio of products and services, including Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules.
Modular robot for automating lab workflows and scientific protocols
System for quick pipetting and sample preparation tasks
Workstation for NGS and proteomics applications
Components for precise liquid handling in research
People of Opentrons
Unlock access to complete
Funding Insights of Opentrons
Opentrons has successfully raised a total of $260.68M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $20.12 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Opentrons
Opentrons has secured backing from 8 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include SoftBank Group, Khosla Ventures and Lerer Hippeau.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
USA focused VC firm investing in seed and early stage startups
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Opentrons
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Opentrons
Opentrons has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Zenify, Zenith AI and Zenith Algorithm.
Investment portfolio details for Opentrons
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of an AI-assisted platform for the analysis of omics data
|
Locked | Locked | 2020 | Locked | |
|
AI application development services are provided for the biopharma sector.
|
Locked | Locked | 2020 | Locked | |
|
Cloud migration services are provided to facilitate infrastructure transitions.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Opentrons
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Opentrons
Detailed financials for Opentrons
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opentrons Comparisons
Peer comparison for Opentrons
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Opentrons
Opentrons operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tecan, Andrew Alliance, LabCyte, Ginolis and Scienion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
Provider of automated liquid handling tools and software for scientific labs
|
|
| Locked | Locked | Locked |
Acoustic liquid handling is developed for life science research.
|
|
| Locked | Locked | Locked |
Liquid handling and lab automation robots
|
|
| Locked | Locked | Locked |
Non-contact dispensing solutions for genomics and proteomics are provided.
|
Detailed competitors of Opentrons
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opentrons
Complete news archive for Opentrons
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opentrons
Opentrons was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Opentrons is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Jonathan Brennan-Badal is the current CEO of Opentrons.
Opentrons is a funded company, having raised a total of $260.68M across 7 funding rounds to date.
Opentrons was founded in 2013 in Brooklyn, United States, within the lab automation sector. The OT-2 personal pipetting robot is produced to automate repetitive benchwork, including fluid transfers via manual micro-pipettes. Scalable hardware and software solutions are offered, with development conducted in an open-source format to support various laboratory activities.
Opentrons's top competitors include Tecan, Andrew Alliance and Scienion.
Opentrons offers Opentrons Flex, Opentrons Flex Prep, OT-2 Workstations, and Pipettes and Modules.
Opentrons has made 3 acquisitions, including Zenify, Zenith AI, and Zenith Algorithm.
Opentrons has 8 investors. Key investors include SoftBank Group, Khosla Ventures, Lerer Hippeau, Sands Capital, and SOSV.
The valuation of Opentrons is $1.8B as of Sep 2021.